MEDIF MEDIPHARM LABS CORP
- 0.063000
- +0.003315+5.55%
MEDIPHARM LABS CORP News
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced its financial results on Wednesday for the full year and three months ended Dec. 31, 2023.Net revenue grew to CA$33 million ($24.3 mi
Earnings Call Summary | MEDIPHARM LABS CORP(MEDIF.US) Q4 2023 Earnings Conference
The following is a summary of the MediPharm Labs Corp. (MEDIF) Q4 2023 Earnings Call Transcript:Financial Performance:MediPharm reported Q4 2023 revenue of $9.1 million, a 63% increase compared to the
MediPharm Labs Reports Q4 Results
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
06:33 AM EDT, 03/27/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%
Notable Earnings Before Wednesday's Open
MediPharm Labs Corp. Brief: Says "Historic Change Is a Significant Positive Step in Removing the Stigma Related to Medical Cannabis"
06:32 AM EDT, 03/25/2024 (MT Newswires) -- MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) has received a GMP certification for its Barrie, Ontario facility from ANVISA, the governing body of Brazil's pharmaceutical industry.This is M
Stocks in Play: MediPharm Labs Corp.
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of arou
MediPharm Labs Reports Q3 Results
Notable Earnings Before Tuesday's Open
New Cannabis Products Energize Global Health & Wellness Market, Including Australia
In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness solutions. From organic CBD sleep gummies to premium cannabis extracts an
MediPharm to Receive Outstanding Settlement of $9M From Tilray
MediPharm Labs Corp. Brief: Says Settled an Outstanding Claim for $9 Million
07:10 AM EDT, 10/02/2023 (MT Newswires) -- MediPharm Labs Corp. Brief: Says Settled an Outstanding Claim for $9 Million
New CBD & THC Cannabis Oils Now Shipping To Australia From Canada
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) announced on Wednesday that Canadian-produced GMP Beacon Medical cannabis oil and inhalation cartridges have launched in the Australian medical
MediPharm Labs Corp. Brief: Launching New GMP Products to the Australian Medical Cannabis Market
07:19 AM EDT, 09/27/2023 (MT Newswires) -- MediPharm Labs Corp. Brief: Launching new GMP Products to the Australian Medical Cannabis Market
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. Ltd., operating as Shelter Cannabis for the Shelter Ca
MediPharm Labs Looks to Improve Sales Margins With Termination of Royalty Payments Deal
MediPharm Labs Corp. Announces Termination of Shelter Cannabis Brands Royalty Agreement
MediPharm Labs Corp. (LABS.TO). a company specialized in precision-based cannabinoids, on Wednesday said it has executed a supplementary agreement to its Asset Purchase Agreement with 1193269 B.C. Ltd
Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found
New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety. MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) said the st
Analysis
Price Target
No Data
